FAFolasade Muibat Adeyemi

Folasade Muibat Adeyemi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Folasade Muibat Adeyemi has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Physiological and microbiota profiling of African catfish ( Clarias gariepinus ) challenged with Bdellovibrio sp.: implications for safe pathogen control in fish production

    by Omotayo O. Oyedara, Rokibat B. Giwa, Oboro O. Abuh, Olaoniye H. Ajigbewu, Folasade M. Adeyemi, Tope G. Atere, Babafemi S. Ajisebiola, Temidayo O. Elufisan, Folorunso W. Sule, Sunday B. Akinde, et al.

    Aquaculture, including fish farming, is recognized by Food and Agriculture Organization (FAO) as one of the fastest-growing agricultural practices and food sectors worldwide (FAO 2020a, 2020b; Taco...

  • Open Access

    Detection of biofilm formation and antibiotic resistance genes in multidrug-resistant Burkholderia sp. isolated from agricultural soil

    by Alabi Peter Dare, Abideen Akinkunmi Wahab, Waidi Folorunso Sule, Folasade Muibat Adeyemi, Nana Aishat Yusuf-Omoloye, Esther Iyanuoluwa Fatoye, Tajudeen David Garuba, Favour Tawa Hassan

    Background: Burkholderia are environmental bacteria mostly distributed in soil and water. Species of these bacteria can cause melioidosis in humans and animals, as well as necrotizing pneumonia in patients with cystic fibrosis. Detection of biofilm formation and antibiotic resistance genes in these bacteria will help to know mechanisms of resistance to drugs for treating infected patients. This study aims to isolate and determine formation of biofilm and presence of antibiotic resistance genes in Burkholderia pseudomallei and Burkholderia cepacia . from agricultural soil. Methods: Burkholderia pseudomallei and Burkholderia cepacia were isolated from agricultural soil and putatively identified by morphological, biochemical, and species-specific amplification of the recA gene. The potential of the isolates to form biofilms, their antibiotic susceptibility, and the presence of β-lactamase ( penA ) and efflux pump ( bpeF ) genes were examined. Results: Eleven Burkholderia pseudomallei and twenty-four Burkholderia cepacia isolates were putatively identified with PCR amplification of recA gene. In all, 82% of B. pseudomallei and 63% of B. cepacia isolates formed biofilm. All isolates showed resistance to imipenem (10 µg), amoxicillin/clavulanate (20/10 µg), meropenem (10 µg), ceftazidime (30 µg), kanamycin (30 µg), and cefotaxime (30 µg), which are conventionally used to treat Burkholderia infections. Again, all B. pseudomallei and B. cepacia had efflux pump bpeF gene, while 27% of B. pseudomallei and 21% of B. cepacia possessed the β-lactamase penA gene. Conclusion: This study isolated biofilm-forming and multidrug-resistant B. pseudomallei and B. cepacia from soil samples. This study suggests that biofilm formation and antibiotic resistance genes may contribute to multidrug resistance in Burkholderia sp.

  • Open Access

    Culturable microbiota of reared mosquito fauna in Osogbo, Nigeria and their potential biological roles: a molecular insight

    by Omotayo O. Oyedara, Sunday O. Olaniyan, Sandra O. Onakhinor, Folasade M. Adeyemi, Abideen A. Wahab, Waidi F. Sule, Babafemi S. Ajisebiola, Temidayo O. Elufisan, Sunday B. Akinde, Monsuru A. Adeleke

    Mosquitoes are vectors of deadly, life-threatening diseases worldwide. There is limited information on the interactions between microbes and local mosquito

  • Concurrent resistance and virulence traits in extremely drug-resistant Burkholderia pseudomallei from bovine milk samples: potential for zoonotic transmission

    by Folasade Muibat Adeyemi, Alimat Olamide Usamat, Alabi Peter Dare, Nana Aishat Yusuf-Omoloye, Omotayo Opemipo Oyedara, Abideen Akinkunmi Wahab, Zainab Adedamola Adeyemi, Esther Abiodun Akinlade, Oyenike Monsurat Jimoh, Olaoniye Habeebat Ajigbewu, et al.

    Background Burkholderia pseudomallei, the causative agent of melioidosis in humans and animals, has been implicated in acute infections with high mortality rates in animal hosts and in mastitis in dairy cattle. It has intrinsic resistance to a wide range of antibiotics and is also known to possess a multitude of virulence determinants. This study provides baseline data on the occurrence of this pathogen in bovine milk samples in Osogbo, Southwestern Nigeria. Methods A total of 371 milk samples collected from dairy cows with clinical and subclinical mastitis were assessed for the presence of B. pseudomallei using phenotypic microbiological techniques, confirmed by molecular methods. Selected resistance (folA, folP, Omp38, bpeE and bpeF) and virulence (bsaU, pili/fimbriae, bimA, tssA and wbiE) genes were screened for using self-designed specific primers, while antibiotic susceptibility testing against clinically relevant antibiotics was via the Kirby-Bauer disc diffusion technique. Results Molecular identification confirmed 16 isolates (4.31%) as B. pseudomallei. Resistance to amoxicillin-clavulanic acid, imipenem, tetracycline and ceftazidime was absolute (100.0%), trailed by trimethoprim-sulfamethoxazole (SXT) at 93.8%. Meropenem exhibited the highest activity in vitro, as 93.8% of isolates were susceptible to it. All isolates (100.0%) were classified as extremely drug-resistant (XDR), with multiple antibiotic resistance indices ≥ 0.2. All isolates (100.0%) also harboured both resistance and virulence determinants, with 68.8% having ≥ 6 genes − 93.75% had the folP gene. The predominant virulence gene was BsaU, detected in 87.5% of isolates. No isolates had the wbiE gene. Conclusion The presence of XDR strains and carriage of multiple resistance and virulence genes in B. pseudomallei strains portend serious implications in affected dairy cattle. This study recommends prudent antibiotic use in dairy cattle and the proper processing of milk before consumption to limit the risk of zoonotic transmission.

  • Open Access

    Genomic surveillance and phylo-evolutionary analysis of SARS-CoV-2 variants in Osun state, Nigeria during the second wave of COVID-19 pandemic

    by Sunday Babatunde Akinde, Omotayo Opemipo Oyedara, Taiwo Samson Olumakinde, Oluwaseyi Paul Olaniyan, Folasade Muibat Adeyemi, Rahman Ayodele Bolarinwa, Omolola Yinka Adeagbo, Timilehin Emmanuel Oluokun, Waidi Folorunso Sule, Olabisi Olaniyi Ojo, et al.

    SARS-CoV-2 genome sequencing, genomic characterization, and global data sharing are recommended to facilitate countermeasures against COVID-19. This study

  • Open Access

    Evaluation of the pharmacological potential of Ganoderma lucidum against haemorrhagic and anticoagulant activities of Echis ocellatus venom

    by O O Oyedara, B S Ajisebiola, O E Abioye, O A Fadare, O A Olatunji, F M Adeyemi, M N Enahoro, S F Popoola, O O Oluyide, Z A Adeyemi

    Echis ocellatus is a highly venomous snake that can cause serious medical complications due to the presence of toxic proteins in its venom. These proteins, such as echicetin and phospholipase A2 (PLA2), often cause severe pathophysiology in snakebite victims. Ganoderma lucidum is recognised for its pharmacological benefits against various diseases. However, the potential of this fungus as an antivenom has not yet been reported. This study investigated the inhibitory effects of G. lucidum on haemorrhagic and anticoagulant activities induced by E. ocellatus venom, and identified its possible bioactive inhibitor compounds using in vitro, in vivo, and in silico methods. Ganoderma lucidum was extracted using methanol in a standard procedure, and varying doses (20 and 40 mg) of the extract were tested against the biological activities E. ocellatus venom. Thereafter, the extract of the G. lucidum was subjected to Gas Chromatography-Mass Spectrometry (GC-MS) analysis to identify its bioactive compounds. The identified compounds were docked against the catalytic active sites of echicetin and PLA2 proteins to determine the best inhibitor compound. The Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties of compounds were determined using the ADMETlab 2.0 web tool. The extract caused 62.96 ± 1.03% and 59.25 ± 1.59% venom-induced haemorrhage inhibition at doses of 20 and 40 mg, respectively, while plasma clotting times were shortened to 132 and 163 s at 20 and 40 mg, respectively. The GC-MS identified 29 bioactive compounds from G. lucidum extract, out of which hesperidin had the highest docking scores of – 9.3 kcal/mol and – 9.9 kcal/mol against the catalytic sites of echicetin and PLA2 enzymes, respectively. The results indicate that G. lucidum has antivenom potential against E. ocellatus venom-induced toxic activities, and identified hesperidin as a promising compound for antivenom exploration against viper envenoming.


  • Open Access

    Carbapenem-resistance in Acinetobacter baumannii: prevalence, antibiotic resistance profile and carbapenemase genes in clinical and hospital environmental strains

    by Folasade Muibat Adeyemi, Esther Abiodun Akinlade, Nana Aishat Yusuf-Omoloye, Olaoniye Habeebat Ajigbewu, Alabi Peter Dare, Abideen Akinkunmi Wahab, Omotayo Opemipo Oyedara, Habeeb Salman Isiaka, Alimat Olamide Usamat

    Acinetobacter baumannii, a Gram-negative member of the ESKAPE pathogen group, is known to develop resistance to several antibiotics rapidly, and carbapenem-resistant A. baumannii (CRAB) is highly implicated in life-threatening infections, especially within hospital settings. This study detected CRAB in clinical and hospital-environmental samples, evaluated the antibiotic resistance patterns and screened for prevalent carbapenemase genes in isolates from a hospital in Southwest Nigeria. A total of 150 clinical and hospital environmental samples were analysed using culture-dependent and molecular methods for the detection of Acinetobacter baumannii. Antibiotic susceptibility test was done using the Kirby-Bauer disk diffusion technique. Phenotypic screening for carbapenemase was via simplified carbapenem inactivation method (sCIM), and molecular detection of blaKPC type, blaOXA−48−like, blaVIM type, blaNDM−1, blaIMP variants and blaOXA−23−like genes by Polymerase chain reaction. Altogether, only 29.4% (42/143 isolates) of recovered isolates were identified as A. baumannii, giving a prevalence of 28.0% (42/150 samples), predominantly from sputum. All isolates had the gluconolactonase gene, while 5/42 had the blaOXA-51-like gene. Resistance to meropenem and cefiderocol was 100.0% and 88.1%, respectively, while gentamicin was most effective in vitro (7.1%); 54.8% were multidrug-resistant, and 88.1% (37/42) had MARI ≥ 0.2. Overall, 39/42 (92.9%) isolates had ≥ one or more carbapenemase genes; 61.9% (26/42) had the blaKPC type gene, 59.5% (25/42) had the blaIMP variants while 45.2% had the blaVIM type gene; no strain had the blaNDM−1 or the blaOXA−23−like gene. This study reports the occurrence of MDR strains, and of blaKPC type, blaIMP variants and blaVIM type carbapenemase genes in A. baumannii isolates from clinical and hospital environmental samples, contributing to the pool of existing data on their occurrence. It also highlights the need for monitoring and continued surveillance of the strains, most especially in the clinical setting.


  • Open Access

    Bacterial predatory potentials of indigenous Bdellovibrio species in southwest Nigeria: Targeting multidrug-resistant Klebsiella pneumoniae and Enterobacter species isolated from chronic wound infections

    by O. H. Ajigbewu, O. O. Oyedara, A. A. Wahab, N. A. Yusuf-Omoloye, F. A. Ajigbewu, F. M. Adeyemi

    Background: Chronic wound infections could become life-threatening conditions when caused by multi-drug-resistant Gram-negative ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp) pathogens. Alternative therapeutic approaches are vital for the therapy of infections caused by these pathogens and one of the biocontrol therapies is the application of Bdellovibrio spp, a Gram-negative bacterium with predatory potential against pathogenic Gram-negative bacteria.Methodology: This study isolated, and phenotypically and genotypically characterized Bdellovibrio spp from environmental sources including soil, pond waters, and faecal materials from cattle and poultry in Osogbo, southwest Nigeria using double-layered agar plating technique, with Klebsiella spp as prey. The prey range and predatory potentials of the isolated Bdellovibrio spp against 25 clinical bacterial isolates including 6 K. pneumoniae and 19 Enterobacter spp, recovered from chronic wound infections, was assessed using the same double-layered agar technique.Results: Five strains of Bdellovibrio isolated formed characteristic plaques on lawns of Klebsiella spp used as prey. At the molecular level, all the five strains, designated UAB, STU, PW2, PW5, and PW6, belonged to the genus Bdellovibrio, however, they exhibited different clustering patterns on the phylogenetic tree. Additionally, the prey range of the five Bdellovibrio strains on the bacterial isolates varied, with UAB, PW6, PW5, and PW2 preying upon 12 (48.0%), 12 (48.0%), 7 (28.0%), and 1 (4.0%) bacterial isolate respectively, while STU did not prey on any of the bacteria isolates.Conclusion: This research presents the first molecular characterization of Bdellovibrio spp in Nigeria, hence serving as a baseline study for future Bdellovibrio research in Nigeria. It also highlights the promising potential of Bdellovibrio spp in control of K. pneumoniae and Enterobacter spp associated with chronic wound infections.

  • Open Access

    Guardians of resistance and virulence: detection of mec, femA, Van, pvl, hlg and spa genes in methicillin and vancomycin-resistant Staphylococcus aureus from clinical and food samples in Southwestern Nigeria

    by Folasade Muibat Adeyemi, Omotayo Opemipo Oyedara, Nana Aishat Yusuf-Omoloye, Olaoniye Habeebat Ajigbewu, Onyinye Lynda Ndaji, Maryam Kikelomo Adegbite-Badmus, Taiwo Samson Olumakinde, Timilehin Emmanuel Oluokun

    Staphylococcus aureus strains are highly virulent and associated with an eclectic range of severe nosocomial and community-acquired infections. This study assessed methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA/VRSA) from clinical and ready-to-eat (RTE) food sources, screened for antibiotic resistance; and molecular determinants of antibiotic and virulence genes. Altogether, 465 clinical and RTE food samples were analyzed via conventional microbiological techniques and S. aureus identification was confirmed by nuc gene detection. Phenotypic screening for methicillin and vancomycin-resistance was by agar-screen cum micro-broth dilution respectively, while antibiotic susceptibility testing was done by the disc-diffusion technique. VanA/vanB/VanC1, femA, mecA/mecC; pvl/hlg and spa gene detection was via Polymerase chain reaction. Phenotypically, 211 Staphylococcal isolates were recovered, 138 (65.4%) of them carrying the nuc gene – all 138 (100.0%) were VRSA, while 59/138 (42.8%) were MRSA phenotypically. Overall, 114/138 (82.6%), 7/138 (5.1%), and 6/138 (4.3%) of isolates had the femA, mecA, and mecC genes, while van genes were detected in only 3 (2.2%) isolates, with virulence determinants pvl, hlg, and spa gene carriage in 8 (5.8%), 10 (7.2%), and 77 (55.8%) isolates respectively. In all, 11.6% carried resistance-associated genes, 55.8% carried virulence genes, and co-detection of resistance and virulence genes was observed in 12.3%. Overall, 96/138 (69.6%) were multidrug-resistant (MDR), while one strain was extremely drug-resistant (XDR). MAR Indices ≥ 0.2 was observed in 83.3% of isolates. This study highlights virulence levels of MRSA and VRSA circulating strains in Osogbo, contributing to their sustained surveillance, and improving available data for successive epidemiology investigations. This study also reports the occurrence of the mecC gene in S. aureus isolates from RTE foods and human samples in Southwestern Nigeria.